{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,27]],"date-time":"2026-06-27T08:35:15Z","timestamp":1782549315276,"version":"3.54.5"},"reference-count":23,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2012,10,1]],"date-time":"2012-10-01T00:00:00Z","timestamp":1349049600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2012,10,1]],"date-time":"2012-10-01T00:00:00Z","timestamp":1349049600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000071","name":"National Institute of Child Health and Human Development","doi-asserted-by":"publisher","award":["U10 HD047891"],"award-info":[{"award-number":["U10 HD047891"]}],"id":[{"id":"10.13039\/100000071","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["ajog.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Obstetrics and Gynecology"],"published-print":{"date-parts":[[2012,10]]},"DOI":"10.1016\/j.ajog.2012.06.064","type":"journal-article","created":{"date-parts":[[2012,8,4]],"date-time":"2012-08-04T03:46:22Z","timestamp":1344051982000},"page":"331.e1-331.e6","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":31,"title":["Transplacental transfer of vancomycin and telavancin"],"prefix":"10.1016","volume":"207","author":[{"given":"Tatiana","family":"Nanovskaya","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Svetlana","family":"Patrikeeva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Zhan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valentina","family":"Fokina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gary D.V.","family":"Hankins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahmoud S.","family":"Ahmed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ajog.2012.06.064_bib1","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1097\/01.AOG.0000175142.79347.12","article-title":"Clinical presentation of community-acquired methicillin-resistant Staphylococcus aureus in pregnancy","volume":"106","author":"Laibl","year":"2005","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ajog.2012.06.064_bib2","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1055\/s-2008-1075032","article-title":"Serious postpartum infection due to MRSA in an asymptomatic carrier: case report and review","volume":"25","author":"Stumpf","year":"2008","journal-title":"Am J Perinatol"},{"key":"10.1016\/j.ajog.2012.06.064_bib3","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1097\/01.AOG.0000269142.19323.88","article-title":"Postpartum iliopsoas pyomyositis due to community-acquired methicillin-resistant Staphylococcus aureus","volume":"110","author":"Sokolov","year":"2007","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ajog.2012.06.064_bib4","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1093\/jac\/40.1.135","article-title":"Methicillin-resistant Staphylococcus aureus clinical strain with reduced vancomycin susceptibility","volume":"40","author":"Hiramatsu","year":"1997","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ajog.2012.06.064_bib5","first-page":"565","article-title":"Staphylococcus aureus resistant to vancomycin\u2013United States, 2002","volume":"51","year":"2002","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.ajog.2012.06.064_bib6","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1086\/381202","article-title":"Treatment outcomes for serious infections caused by methicillin-resistant Staphylococcus aureus with reduced vancomycin susceptibility","volume":"38","author":"Howden","year":"2004","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ajog.2012.06.064_bib7","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1093\/jac\/dkl235","article-title":"Comparative activity of the new lipoglycopeptide telavancin in the presence and absence of serum against 50 glycopeptide nonsusceptible staphylococci and three vancomycin-resistant Staphylococcus aureus","volume":"58","author":"Leuthner","year":"2006","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ajog.2012.06.064_bib8","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1093\/jac\/dkh156","article-title":"Comparative in vitro activity of telavancin (TD-6424), a rapidly bactericidal, concentration dependent antiinfective with multiple mechanism of action against gram-positive bacteria","volume":"53","author":"King","year":"2004","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ajog.2012.06.064_bib9","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1093\/jac\/dkm211","article-title":"Comparative activity of telavancin against isolates of community-associated methicillin-resistant Staphylococcus aureus","volume":"60","author":"Saravolatz","year":"2007","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ajog.2012.06.064_bib10","doi-asserted-by":"crossref","first-page":"2149","DOI":"10.1128\/AAC.48.6.2149-2152.2004","article-title":"In vitro activities of the new semisynthetic glycopeptide telavancin (TD-6424), vancomycin, daptomycin, linezolid, and four comparator agents anaerobic gram-positive species and Corynebacterium spp","volume":"48","author":"Goldstein","year":"2004","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ajog.2012.06.064_bib11","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1128\/AAC.49.3.1127-1134.2005","article-title":"Telavancin, a multifunctional lipoglycopeptide, disrupts both cell wall synthesis and cell membrane integrity in methicillin-resistant Staphylococcus aureus","volume":"29","author":"Higgins","year":"2005","journal-title":"Antimicrob Chemother"},{"key":"10.1016\/j.ajog.2012.06.064_bib12","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1080\/10647440400009821","article-title":"Transplacental passage of vancomycin in the ex vivo human perfusion model","volume":"12","author":"Hnat","year":"2004","journal-title":"Infect Dis Obstet Gynecol"},{"key":"10.1016\/j.ajog.2012.06.064_bib13","first-page":"908","article-title":"Transplacental passage of vancomycin during the second trimester of pregnancy","volume":"78","author":"Bourget","year":"1991","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ajog.2012.06.064_bib14","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1097\/01.AOG.0000260388.78339.b6","article-title":"Transplacental passage of vancomycin in noninfected term pregnant women","volume":"109","author":"Laiprasert","year":"2007","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ajog.2012.06.064_bib15","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1124\/jpet.300.1.26","article-title":"Transplacental transfer and metabolism of buprenorphine","volume":"300","author":"Nanovskaya","year":"2002","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.ajog.2012.06.064_bib16","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1159\/000410672","article-title":"Human placenta in vitro: characterization during 12 hours of dual perfusion","volume":"13","author":"Miller","year":"1985","journal-title":"Contrib Gynecol Obstet"},{"key":"10.1016\/j.ajog.2012.06.064_bib17","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1111\/j.1471-0528.1984.tb03700.x","article-title":"Changes in serum albumin and alpha acid glycoprotein concentrations during pregnancy: an analysis of fetal-maternal pairs","volume":"91","author":"Krauer","year":"1984","journal-title":"BJOG"},{"key":"10.1016\/j.ajog.2012.06.064_bib18","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1016\/j.bcp.2009.10.026","article-title":"Modulation of human placental P-glycoprotein expression and activity by MDR1 gene polymorphisms","volume":"79","author":"Hemauer","year":"2010","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.ajog.2012.06.064_bib19","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1023\/A:1022290523347","article-title":"Kinetic analysis of P-glycoprotein-mediated transport by using normal human placental brush-border membrane vesicles","volume":"20","author":"Ushigome","year":"2003","journal-title":"Pharm Res"},{"key":"10.1016\/j.ajog.2012.06.064_bib20","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1016\/j.ajog.2006.05.047","article-title":"Transfer of metformin across the dually perfused human placental lobule","volume":"195","author":"Nanovskaya","year":"2006","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2012.06.064_bib21","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.bcp.2004.09.008","article-title":"Bidirectional transfer of methadone across human placenta","volume":"69","author":"Nekhayeva","year":"2005","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.ajog.2012.06.064_bib22","series-title":"Placental toxicology","first-page":"1","article-title":"Techniques: in vitro perfusion of human placenta","author":"Schneider","year":"1995"},{"key":"10.1016\/j.ajog.2012.06.064_bib23","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1128\/AAC.49.1.195-201.2005","article-title":"Pharmacokinetics, serum inhibitory and bactericidal activity, and safety of telavancin in healthy subjects","volume":"49","author":"Shaw","year":"2005","journal-title":"Antimicrob Agents Chemother"}],"container-title":["American Journal of Obstetrics and Gynecology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002937812007181?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002937812007181?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T10:45:49Z","timestamp":1757587549000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002937812007181"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,10]]},"references-count":23,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2012,10]]}},"alternative-id":["S0002937812007181"],"URL":"https:\/\/doi.org\/10.1016\/j.ajog.2012.06.064","relation":{},"ISSN":["0002-9378"],"issn-type":[{"value":"0002-9378","type":"print"}],"subject":[],"published":{"date-parts":[[2012,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Transplacental transfer of vancomycin and telavancin","name":"articletitle","label":"Article Title"},{"value":"American Journal of Obstetrics and Gynecology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajog.2012.06.064","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2012 Mosby, Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}